TelyRx Holdings Inc. (TSX:TELY)

TelyRx Holdings Statistics

Total Valuation

TelyRx Holdings has a market cap or net worth of CAD 124.45 million. The enterprise value is 104.64 million.

Market Cap	124.45M
Enterprise Value	104.64M

Important Dates

The next estimated earnings date is Tuesday, August 11, 2026.

Earnings Date	Aug 11, 2026
Ex-Dividend Date	n/a

Share Statistics

TelyRx Holdings has 46.96 million shares outstanding.

Current Share Class	24.47M
Shares Outstanding	46.96M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.43%
Owned by Insiders (%)	8.89%
Owned by Institutions (%)	n/a
Float	24.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.61
PB Ratio	6.36
P/TBV Ratio	6.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.45
EV / Sales	1.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-27.94

Financial Position

The company has a current ratio of 3.90, with a Debt / Equity ratio of 0.91.

Current Ratio	3.90
Quick Ratio	3.62
Debt / Equity	0.91
Debt / EBITDA	n/a
Debt / FCF	-4.77
Interest Coverage	-9.98

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-29.16%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, TelyRx Holdings has paid 25,125 in taxes.

Income Tax	25,125
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	42.16
Average Volume (20 Days)	6,519

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TelyRx Holdings had revenue of CAD 77.31 million and -14.05 million in losses. Loss per share was -1.30.

Revenue	77.31M
Gross Profit	42.62M
Operating Income	-10.80M
Pretax Income	-14.02M
Net Income	-14.05M
EBITDA	-10.80M
EBIT	-10.80M
Loss Per Share	-1.30

Balance Sheet

The company has 37.68 million in cash and 17.87 million in debt, with a net cash position of 19.82 million or 0.42 per share.

Cash & Cash Equivalents	37.68M
Total Debt	17.87M
Net Cash	19.82M
Net Cash Per Share	0.42
Equity (Book Value)	19.57M
Book Value Per Share	0.74
Working Capital	31.04M

Cash Flow

In the last 12 months, operating cash flow was -3.10 million and capital expenditures -646,283, giving a free cash flow of -3.75 million.

Operating Cash Flow	-3.10M
Capital Expenditures	-646,283
Depreciation & Amortization	-1,384
Net Borrowing	3.87M
Free Cash Flow	-3.75M
FCF Per Share	-0.08

Margins

Gross margin is 55.13%, with operating and profit margins of -13.97% and -18.17%.

Gross Margin	55.13%
Operating Margin	-13.97%
Pretax Margin	-18.14%
Profit Margin	-18.17%
EBITDA Margin	-13.97%
EBIT Margin	-13.97%
FCF Margin	n/a

Dividends & Yields

TelyRx Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-11.29%
FCF Yield	-3.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 7, 2026. It was a reverse split with a ratio of 0.0333333.

Last Split Date	Apr 7, 2026
Split Type	Reverse
Split Ratio	0.0333333

Scores

TelyRx Holdings has an Altman Z-Score of 0.48 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.48
Piotroski F-Score	3